Supply chain issues exacerbated by the COVID-19 pandemic have led leaders at health systems across the U.S. to develop innovative solutions to manage disruptions.
Houston-based respirator manufacturer Aegle plans to develop a five-layer children’s mask to protect against the transmission of COVID-19, other airborne particles and pollution from wildfires, the company said Jan. 27.
The monoclonal antibody therapies made by Regeneron and Eli Lilly, which the omicron coronavirus variant has essentially rendered useless, are still in high use in 12 states, Kaiser Health News reported Jan. 21.
The CDC’s National Institute for Occupational Safety and Health faces a backlog of applications from manufacturers seeking regulatory approval for N95s and other air-filtering masks, Roll Call reported Jan. 19.